-
A Quantitative‐EEG Assessment of Alpha‐1062, a Novel Pro‐Drug of Galantamine for the Treatment of Mild to Moderate Dementia Associated with Alzheimer’s Disease.2022 Alzheimer s & Dementia article Medicine Cholinesterase and Neurodegenerative Diseases cited by 1 patent
Denis G. Kay, Ellen Stijl‐’t Hart, Klaus Linkenkaer‐Hansen, Frederick D. Sancilio, J. Bryce Ortiz, Geert Jan Groeneveld, +1 more
0citations -
CVN293, an Investigational Inhibitor of KCNK13 Targeting NLRP3‐Mediated Neuroinflammation in Neurodegenerative Disease: A Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics.2025 Alzheimer s & Dementia article Biochemistry, Genetics and Molecular Biology Inflammasome and immune disorders Open access
Louise Dickson, Roberto Tolando, Celina Scholl, Michelle Charles, Dino Ossola, Kim L. Matthews, +8 more
0citations
2 results